Nurix Therapeutics Inc. (NRIX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Nurix Therapeutics Inc.

    NASDAQ: NRIX · Real-Time Price · USD
    8.93
    0.60 (7.20%)
    At close: Sep 26, 2025, 3:59 PM
    8.93
    0.00%
    After-hours: Sep 26, 2025, 04:20 PM EDT

    Nurix Therapeutics Income Statement

    Financials in USD. Fiscal year is December - November.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Nov 30, 2024 Nov 30, 2023 Nov 30, 2022 Nov 30, 2021
    Revenue
    		 54.55M 76.99M 38.63M 29.75M
    Cost of Revenue
    		 16.43M 13.65M 10.81M 6.08M
    Gross Profit
    		 38.12M 63.33M 27.82M 23.67M
    Operating Income
    		 -213.03M -155.06M -183.87M -117.89M
    Interest Income
    		 19.73M 11.12M 3.51M 823K
    Pretax Income
    		 -193.3M -143.95M -180.36M -117.06M
    Net Income
    		 -193.57M -143.95M -180.36M -117.19M
    Selling & General & Admin
    		 45.94M 42.9M 38M 31.2M
    Research & Development
    		 221.63M 189.15M 184.5M 116.43M
    Other Expenses
    		 -16.43M -13.65M -10.81M -6.08M
    Operating Expenses
    		 251.15M 218.4M 211.69M 141.55M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 267.58M 232.05M 222.49M 147.64M
    Income Tax Expense
    		 270K n/a -14.31M 131K
    Shares Outstanding (Basic)
    		 67.12M 54.34M 48.61M 42.9M
    Shares Outstanding (Diluted)
    		 67.12M 54.34M 48.61M 42.9M
    EPS (Basic)
    		 -2.88 -2.65 -3.71 -2.73
    EPS (Diluted)
    		 -2.88 -2.65 -3.71 -2.73
    EBITDA
    		 -196.6M -141.41M -173.06M -111.8M
    EBIT
    		 -213.03M -155.06M -183.87M -117.89M
    Depreciation & Amortization
    		 16.43M 13.65M 10.81M 6.08M

    Add to Watchlist